Suchergebnisse - "Rodríguez-Tajes, Sergio"

PubPharm (6)

1

The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Rodríguez-Tajes, S. | García-Eliz, M. | Marcos, A. | +17

2

Reply to : Optimal hepatitis B vaccination schedule for cirrhotic patients: a still unanswered question

enthalten in: Journal of viral hepatitis | 2021

von Rodríguez-Tajes, S. | Lens, S. | Forns, X.

CommentOn: J Viral Hepat. 2021 Jul;28(7):1019-1024. - PMID 33763966

3

One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Palom, A. | Sopena, S. | Riveiro-Barciela, M. | +14

CommentIn: Aliment Pharmacol Ther. 2021 Aug;54(4):519-520. - PMID 34331811

4

Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients

enthalten in: Journal of hepatology | 2021

von García-López, M. | Lens, S. | Pallett, L. | +14

5

Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy

enthalten in: Journal of viral hepatitis | 2021

von Rodríguez-Tajes, S. | Miralpeix, A. | Costa, J. | +6

CommentIn: Eur J Clin Microbiol Infect Dis. 2023 Jun;42(6):799-801. - PMID 37084117

6

Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals

enthalten in: Journal of gastroenterology and hepatology | 2020

von Rodríguez-Tajes, S. | Domínguez, �. | Carrión, J. | +17

1
[1]